Analyst Upside

AU · rank #19 · 2026-07-27

HNGE

NYSE · $5.75B (USD)

SignalBuy1.1strength 1.1 / 10
verdict · PROCEED

The exact numbers the algorithm saw.

Factor scores and the inputs behind this pick.
Composite score
Z-score blend of all factors below.
0.831
EPS revisions (30d)
Change in consensus EPS estimate over the past 30 days ($/share).
+$0.06
Net revisions (30d)
Number of analysts revising upward minus downward.
10
Insider signal (90d)
$0 across 0 unique buyers.
-0.109
Analyst upside
Consensus target $90.87
+22.3%
Momentum acceleration
3-month minus 12-month momentum.
+50.50%
Analyst rating
5 = Strong Buy, 1 = Strong Sell.
Gross margin TTM+81.0%
52w high$91.50
Market cap (USD)$5.75B

The AI research card

Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.

Summary

Hinge Health (HNGE) operates a digital musculoskeletal care platform combining virtual physical therapy, connected hardware, and clinical care teams sold to employers and health plans, scaling to ~$588M revenue in 2025 with low-to-mid-80s non-GAAP gross margins.

Rationale

The analyst_upside signal is reinforced by a 13-analyst consensus with 91.7% revision agreement, five target raises in 30 days, a 13.3% Q1 earnings beat, raised full-year guidance, and 60-to-90-day EPS revisions trending sharply higher — all consistent with a genuine estimate-revision cycle rather than noise.

Material risks

  • 1Commoditization of motion-tracking, telehealth, and AI-based PT tools could erode Hinge's technology differentiation and compress the ~83-85% gross margins that underpin the premium valuation, and the brief explicitly flags no sole-source or long-term backlog guaranteeing multi-year revenue visibility.
  • 2The 2025 GAAP net loss of ~$528M driven by heavy stock-based compensation creates a wide GAAP/non-GAAP gap; if employer customers slow adoption or build in-house alternatives, the non-GAAP profitability narrative unravels quickly given the dilution overhang.

AI verdict council

Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.

OpenAI
Proceed
Claude
Proceed
Gemini
Error